Chugai And Taisho Toyama Launch Bonviva For Osteoporosis In Japan
This article was originally published in PharmAsia News
Executive Summary
Chugai and Taisho Toyama launched Bonviva 1mg syringe (ibandronate) for treatment of osteoporosis in Japan Aug. 29.